Engelsk

The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 Formulär  
  1. StudyEvent: NEI Age-Related Eye Disease Study (AREDS)
    1. Eligibility Criteria
    2. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    3. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    9. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    10. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    15. Subject - Consent Information
    16. Subject - Sample Mapping (including mapping to Coriell IDs)
    17. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
pht000379
Beskrivning

pht000379

DUMMY ID NUMBER
Beskrivning

ID2

Datatyp

string

Alias
UMLS CUI [1,1]
C2348585
STUDY VISIT NUMBER (ALL PARTICIPANTS)
Beskrivning

VISNO

Datatyp

text

Alias
UMLS CUI [1,1]
C3274381
UMLS CUI [1,2]
C0545082
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
IRIS PIGMENTATION RT EYE (ALL PARTICIPANTS)
Beskrivning

REIRISCO

Datatyp

text

Alias
UMLS CUI [1,1]
C0022077
UMLS CUI [1,2]
C0229089
UMLS CUI [1,3]
C0031911
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
NUCLEAR COLOR RT EYE (ALL PARTICIPANTS)
Beskrivning

RENUCCOL

Datatyp

text

Alias
UMLS CUI [1,1]
C0229089
UMLS CUI [1,2]
C0521447
UMLS CUI [1,3]
C0009393
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
NUCLEAR SCLEROSIS RT EYE (ALL PARTICIPANTS)
Beskrivning

RENUCSCL

Datatyp

float

Alias
UMLS CUI [1,1]
C0521447
UMLS CUI [1,2]
C0036429
UMLS CUI [1,3]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
CORTICAL OPACITY W/IN 5 MM RT EYE (ALL PARTICIPANTS)
Beskrivning

REPCTCOL

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C2938874
UMLS CUI [1,2]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
PSC OPACITY W/IN 5 MM RT EYE (ALL PARTICIPANTS)
Beskrivning

REPCTPSC

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C0229089
UMLS CUI [1,2]
C4228349
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
CORTICAL OPACITY IN WHOLE FIELD RT EYE (ALL PARTICIPANTS)
Beskrivning

REPCTCOA

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C0229089
UMLS CUI [1,2]
C2938874
UMLS CUI [1,3]
C0439810
UMLS CUI [1,4]
C1521738
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
IRIS PIGMENTATION LT EYE (ALL PARTICIPANTS)
Beskrivning

LEIRISCO

Datatyp

text

Alias
UMLS CUI [1,1]
C0229090
UMLS CUI [1,2]
C0022077
UMLS CUI [1,3]
C0031911
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
NUCLEAR COLOR LT EYE (ALL PARTICIPANTS)
Beskrivning

LENUCCOL

Datatyp

text

Alias
UMLS CUI [1,1]
C0229090
UMLS CUI [1,2]
C0521447
UMLS CUI [1,3]
C0009393
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
NUCLEAR SCLEROSIS LT EYE (ALL PARTICIPANTS)
Beskrivning

LENUCSCL

Datatyp

float

Alias
UMLS CUI [1,1]
C0521447
UMLS CUI [1,2]
C0036429
UMLS CUI [1,3]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
CORTICAL OPACITY W/IN 5 MM LT EYE (ALL PARTICIPANTS)
Beskrivning

LEPCTCOL

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C0229090
UMLS CUI [1,2]
C2938874
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
PSC OPACITY W/IN 5 MM LT EYE (ALL PARTICIPANTS)
Beskrivning

LEPCTPSC

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C4228349
UMLS CUI [1,2]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
CORTICAL OPACITY IN WHOLE FIELD LT EYE (ALL PARTICIPANTS)
Beskrivning

LEPCTCOA

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C0229090
UMLS CUI [1,2]
C2938874
UMLS CUI [1,3]
C1521738
UMLS CUI [1,4]
C0439810
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
NUCLEAR SCLEROSIS RT EYE - RESCALED (ALL PARTICIPANTS)
Beskrivning

RENUCADJ

Datatyp

float

Alias
UMLS CUI [1,1]
C0229089
UMLS CUI [1,2]
C0521447
UMLS CUI [1,3]
C0036429
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
NUCLEAR SCLEROSIS LT EYE - RESCALED (ALL PARTICIPANTS)
Beskrivning

LENUCADJ

Datatyp

float

Alias
UMLS CUI [1,1]
C0229090
UMLS CUI [1,2]
C0521447
UMLS CUI [1,3]
C0036429
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
YEARS FROM RANDOMIZATION TO DATE OF NEITZ PHOTO RT EYE (ALL PARTICIPANTS)
Beskrivning

RENZTIME

Datatyp

float

Måttenheter
  • years
Alias
UMLS CUI [1,1]
C0439234
UMLS CUI [1,2]
C0034656
UMLS CUI [1,3]
C0200189
UMLS CUI [1,4]
C0011008
UMLS CUI [1,5]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
years
YEARS FROM RANDOMIZATION TO DATE OF SLIT LAMP PHOTO RT EYE (ALL PARTICIPANTS)
Beskrivning

RESLTIME

Datatyp

float

Måttenheter
  • years
Alias
UMLS CUI [1,1]
C0439234
UMLS CUI [1,2]
C0419360
UMLS CUI [1,3]
C0034656
UMLS CUI [1,4]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
years
YEARS FROM RANDOMIZATION TO DATE OF NEITZ PHOTO LT EYE (ALL PARTICIPANTS)
Beskrivning

LENZTIME

Datatyp

float

Måttenheter
  • years
Alias
UMLS CUI [1,1]
C0439234
UMLS CUI [1,2]
C0034656
UMLS CUI [1,3]
C0200189
UMLS CUI [1,4]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
years
YEARS FROM RANDOMIZATION TO DATE OF SLIT LAMP PHOTO LT EYE (ALL PARTICIPANTS)
Beskrivning

LESLTIME

Datatyp

float

Måttenheter
  • years
Alias
UMLS CUI [1,1]
C0439234
UMLS CUI [1,2]
C0034656
UMLS CUI [1,3]
C0419360
UMLS CUI [1,4]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
years
LAST PHOTO IN CLINICAL TRIAL (ALL PARTICIPANTS)
Beskrivning

LASTCLINL

Datatyp

text

Alias
UMLS CUI [1,1]
C2347804
UMLS CUI [1,2]
C1517741
UMLS CUI [1,3]
C0200189
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
Tillbaka till toppen

Similar models

The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 Formulär
  1. StudyEvent: NEI Age-Related Eye Disease Study (AREDS)
    1. Eligibility Criteria
    2. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    3. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    9. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    10. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    15. Subject - Consent Information
    16. Subject - Sample Mapping (including mapping to Coriell IDs)
    17. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
pht000379
ID2
Item
DUMMY ID NUMBER
string
C2348585 (UMLS CUI [1,1])
Item
STUDY VISIT NUMBER (ALL PARTICIPANTS)
text
C3274381 (UMLS CUI [1,1])
C0545082 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
VISNO
Code List
STUDY VISIT NUMBER (ALL PARTICIPANTS)
CL Item
Baseline visit (00)
C1442488 (UMLS CUI [1,1])
C0545082 (UMLS CUI [1,2])
CL Item
0.5-year (01)
C0444500 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
1-year (02)
C0205447 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
1.5-years (03)
C0439234 (UMLS CUI [1,1])
CL Item
2-years (04)
C0205448 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
2.5-years (05)
C3844011 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
3-years (06)
C0439234 (UMLS CUI [1,1])
C0205437 (UMLS CUI [1,2])
CL Item
3.5-years (07)
C0439234 (UMLS CUI [1,1])
CL Item
4-years (08)
C0205450 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
4.5-years (09)
C0439234 (UMLS CUI [1,1])
CL Item
5-years (10)
C0205451 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
5.5-years (11)
C0439234 (UMLS CUI [1,1])
CL Item
6-years (12)
C0205452 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
6.5-years (13)
C0439234 (UMLS CUI [1,1])
CL Item
7-years (14)
C0205453 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
7.5-years (15)
C0439234 (UMLS CUI [1,1])
CL Item
8-years (16)
C0205454 (UMLS CUI [1,1])
C0439234 (UMLS CUI [1,2])
CL Item
8.5-years (17)
C0439234 (UMLS CUI [1,1])
CL Item
9-years (18)
C0439234 (UMLS CUI [1,1])
CL Item
9.5-years (19)
C0439234 (UMLS CUI [1,1])
CL Item
10-years (20)
C0439234 (UMLS CUI [1,1])
CL Item
10.5-years (21)
C0439234 (UMLS CUI [1,1])
CL Item
11-years (22)
C0439234 (UMLS CUI [1,1])
CL Item
11.5-years (23)
C0439234 (UMLS CUI [1,1])
CL Item
12-years (24)
C0439234 (UMLS CUI [1,1])
CL Item
12.5-years (25)
C0439234 (UMLS CUI [1,1])
CL Item
13-years (26)
C0439234 (UMLS CUI [1,1])
Item
IRIS PIGMENTATION RT EYE (ALL PARTICIPANTS)
text
C0022077 (UMLS CUI [1,1])
C0229089 (UMLS CUI [1,2])
C0031911 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
REIRISCO
Code List
IRIS PIGMENTATION RT EYE (ALL PARTICIPANTS)
CL Item
Less than or equal to Std. 1 (1)
CL Item
Less than or equal to Std. 2 (2)
CL Item
Less than or equal to Std. 3 (3)
CL Item
More than Std. 3 (4)
CL Item
Cannot grade (8)
C1707258 (UMLS CUI [1,1])
Item
NUCLEAR COLOR RT EYE (ALL PARTICIPANTS)
text
C0229089 (UMLS CUI [1,1])
C0521447 (UMLS CUI [1,2])
C0009393 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RENUCCOL
Code List
NUCLEAR COLOR RT EYE (ALL PARTICIPANTS)
CL Item
Less than or equal to Std. 2 (1)
CL Item
Less than or equal to Std. 4 (2)
CL Item
Less than or equal to Std. 8 (3)
CL Item
More than Std. 8 (4)
CL Item
Cannot grade (8)
C1707258 (UMLS CUI [1,1])
RENUCSCL
Item
NUCLEAR SCLEROSIS RT EYE (ALL PARTICIPANTS)
float
C0521447 (UMLS CUI [1,1])
C0036429 (UMLS CUI [1,2])
C0229089 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
REPCTCOL
Item
CORTICAL OPACITY W/IN 5 MM RT EYE (ALL PARTICIPANTS)
float
C2938874 (UMLS CUI [1,1])
C0229089 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
REPCTPSC
Item
PSC OPACITY W/IN 5 MM RT EYE (ALL PARTICIPANTS)
float
C0229089 (UMLS CUI [1,1])
C4228349 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
REPCTCOA
Item
CORTICAL OPACITY IN WHOLE FIELD RT EYE (ALL PARTICIPANTS)
float
C0229089 (UMLS CUI [1,1])
C2938874 (UMLS CUI [1,2])
C0439810 (UMLS CUI [1,3])
C1521738 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
IRIS PIGMENTATION LT EYE (ALL PARTICIPANTS)
text
C0229090 (UMLS CUI [1,1])
C0022077 (UMLS CUI [1,2])
C0031911 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LEIRISCO
Code List
IRIS PIGMENTATION LT EYE (ALL PARTICIPANTS)
CL Item
Less than or equal to Std. 1 (1)
CL Item
Less than or equal to Std. 2 (2)
CL Item
Less than or equal to Std. 3 (3)
CL Item
More than Std. 3 (4)
CL Item
Cannot grade (8)
C1707258 (UMLS CUI [1,1])
Item
NUCLEAR COLOR LT EYE (ALL PARTICIPANTS)
text
C0229090 (UMLS CUI [1,1])
C0521447 (UMLS CUI [1,2])
C0009393 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LENUCCOL
Code List
NUCLEAR COLOR LT EYE (ALL PARTICIPANTS)
CL Item
Less than or equal to Std. 2 (1)
CL Item
Less than or equal to Std. 4 (2)
CL Item
Less than or equal to Std. 8 (3)
CL Item
More than Std. 8 (4)
CL Item
Cannot grade (8)
LENUCSCL
Item
NUCLEAR SCLEROSIS LT EYE (ALL PARTICIPANTS)
float
C0521447 (UMLS CUI [1,1])
C0036429 (UMLS CUI [1,2])
C0229090 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LEPCTCOL
Item
CORTICAL OPACITY W/IN 5 MM LT EYE (ALL PARTICIPANTS)
float
C0229090 (UMLS CUI [1,1])
C2938874 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LEPCTPSC
Item
PSC OPACITY W/IN 5 MM LT EYE (ALL PARTICIPANTS)
float
C4228349 (UMLS CUI [1,1])
C0229090 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LEPCTCOA
Item
CORTICAL OPACITY IN WHOLE FIELD LT EYE (ALL PARTICIPANTS)
float
C0229090 (UMLS CUI [1,1])
C2938874 (UMLS CUI [1,2])
C1521738 (UMLS CUI [1,3])
C0439810 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RENUCADJ
Item
NUCLEAR SCLEROSIS RT EYE - RESCALED (ALL PARTICIPANTS)
float
C0229089 (UMLS CUI [1,1])
C0521447 (UMLS CUI [1,2])
C0036429 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LENUCADJ
Item
NUCLEAR SCLEROSIS LT EYE - RESCALED (ALL PARTICIPANTS)
float
C0229090 (UMLS CUI [1,1])
C0521447 (UMLS CUI [1,2])
C0036429 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RENZTIME
Item
YEARS FROM RANDOMIZATION TO DATE OF NEITZ PHOTO RT EYE (ALL PARTICIPANTS)
float
C0439234 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0200189 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0229089 (UMLS CUI [1,5])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RESLTIME
Item
YEARS FROM RANDOMIZATION TO DATE OF SLIT LAMP PHOTO RT EYE (ALL PARTICIPANTS)
float
C0439234 (UMLS CUI [1,1])
C0419360 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,3])
C0229089 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LENZTIME
Item
YEARS FROM RANDOMIZATION TO DATE OF NEITZ PHOTO LT EYE (ALL PARTICIPANTS)
float
C0439234 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0200189 (UMLS CUI [1,3])
C0229090 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LESLTIME
Item
YEARS FROM RANDOMIZATION TO DATE OF SLIT LAMP PHOTO LT EYE (ALL PARTICIPANTS)
float
C0439234 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0419360 (UMLS CUI [1,3])
C0229090 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
LAST PHOTO IN CLINICAL TRIAL (ALL PARTICIPANTS)
text
C2347804 (UMLS CUI [1,1])
C1517741 (UMLS CUI [1,2])
C0200189 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LASTCLINL
Code List
LAST PHOTO IN CLINICAL TRIAL (ALL PARTICIPANTS)
CL Item
Yes (Y)
Tillbaka till toppen